DTU Logo
Publications | Conference abstracts | Slidesets | Webcasts

Publications (10 of 430)

Search Publications :


The UKPDS: implications for the dyslipidaemic patient
Holman R
Acta Diabetologica 2001;38 Suppl 1:S9-S14. Published:Sep-2006. PMID:11829452. doi:10.1007/s005920170003

The UKPDS Risk Engine: a model for the risk of coronary heart disease in type 2 diabetes
Stevens RJ, Kothari V, Adler AI, Stratton IM; United Kingdom Prospective Diabetes Study (UKPDS) Group
Clinical Science 2001;101:671-679. Published:Dec-2001. PMID:11724655. doi:10.1042/cs1010671
Erratum in :
Clinical Science 2002;102:679, Print:Jun-2002, doi:10.1042/cs1020679

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
Clarke R, Lewington S, Donald A, Johnston C, Refsum H, Stratton IM, Jacques P, Breteler MMB, Holman R
Journal of Cardiovascular Risk 2001;8:363-369. Published:Dec-2001. PMID:11873092
[Full text] [Abstract]

Butyrylcholinesterase K variant on chromsome 3q is associated with Type II diabetes in white Caucasian subjects
Hashim Y, Shepherd D, Wiltshire S, Holman RR, Levy JC, Clark A, et al.
Diabetologia 2001;44:2227-2230. Published:Dec-2001. PMID:11793025. doi:10.1007/s001250100033
Erratum in :
Diabetologia 2002;45:459, Print:Mar-2002

Relationship between ethnicity and glycaemic control, lipid profiles and blood pressure during the first nine years of Type 2 diabetes
Davis TM, Cull CA, Holman RR; U.K. Prospective Diabetes Study (UKPDS) Group
Diabetes Care 2001;24:1167-1173. Published:Jul-2001. PMID:11423497. doi:10.2337/diacare.24.7.1167

An economic evaluation of atenolol versus captopril in patients with Type 2 diabetes
Gray A, Clarke P, Raikou M, Stevens R, Neil A, Cull C, Stratton I, Holman R
Diabetes Medicine 2001;18:438-444. Published:Jun-2001. Epub:20-Dec-2001. PMID:11472461. doi:10.1046/j.1464-5491.2001.00485.x

Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53)
Gloyn AL, Hashim Y, Ashcroft SJ, Ashfield R, Wiltshire S, Turner RC.
Diabetic Medicine 2001;18:206-12. Published:Mar-2001. Epub:20-Dec-2001. PMID:11318841. doi:10.1046/j.1464-5491.2001.00449.x
Erratum in :
Diabetic Medicine 2003;20:252, Print:Mar-2003

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52)
Kohner EM, Stratton IM, Aldington SJ, Holman RR, Matthews DR.
Diabetic Medicine 2001;18:178-184. Published:Mar-2001. Epub:20-Dec-2001. PMID:11318837. doi:10.1046/j.1464-5491.2001.00458.x

Cost-effective analysis of intensive blood glucose control with metformin in overweight patients with type 2 diabetes (UKPDS 51).
Clarke P, Gray A, Adler A, Stevens R, Raikou M, Cull C, Stratton I, Holman R; UKPDS Group. United Kingdom Prospective Diabetes Study
Diabetologia 2001;44:298-304. Published:Mar-2001. PMID:11317659. doi:10.1007/s001250051617

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis
Stratton IM, Kohner EM, Aldington SJ, Turner RC, Manley SE, Matthews DR
Diabetologia 2001;44:1546-163. Published:Feb-2001. PMID:11270671. doi:10.1007/s001250051594